SAB Biotherapeutics, Inc. — SCHEDULE 13D/A Filings
2 SCHEDULE 13D/A filings on record
This page lists all SCHEDULE 13D/A filings submitted to the SEC by SAB Biotherapeutics, Inc. (SABSW), sorted by most recent first. Each row links to the full filing on EdgarLookup. SAB Biotherapeutics, Inc. has filed 2 SCHEDULE 13D/A documents with the SEC since 2020. To view all SEC filings by SAB Biotherapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
25-NSE
3
4
4/A
424B3
424B4
424B5
425
5
8-A12B
8-K
8-K/A
AW
CERT
CORRESP
D
DEF 14A
DEFA14A
DRSLTR
EFFECT
NT 10-K
NT 10-Q
POS AM
PRE 14A
RW
S-1
S-1/A
S-3
S-3/A
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13D/A | — | 0001346824-26-000079 | Mar 23, 2026 | — |
| SCHEDULE 13D/A | — | 0001346824-26-000072 | Mar 11, 2026 | — |